Bionano Genomics Inc.
BNGO | NASDAQ
$1.83
+$0.10 (+5.78%)
At close: Sep 21, 2026, 4:00 PM ET
$1.87
+$0.04 (+2.19%)
After-hours:
Sep 21, 2026, 7:56 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 28.51M | 30.78M | 36.12M | 27.8M | 17.98M | 8.5M |
Cost of Revenue | 22.25M | 30.4M | 26.55M | 21.86M | 14.11M | 5.73M |
Gross Profit | 6.26M | 380K | 9.57M | 5.95M | 3.87M | 2.77M |
Operating Income | -33.34M | -103.98M | -215.25M | -131.7M | -77.1M | -38.55M |
Interest Income | 1.11M | 2.1M | 3.31M | 1.51M | 236K | n/a |
Pretax Income | -26.33M | -111.98M | -232.43M | -130.71M | -78.15M | -41.08M |
Net Income | -26.4M | -112.02M | -232.49M | -132.6M | -72.44M | -41.11M |
Selling & General & Admin | 28.22M | 51.86M | 94.96M | 88.6M | 58.49M | n/a |
Research & Development | 11.37M | 24.8M | 54.03M | 49.05M | 22.49M | 10.26M |
Other Expenses | n/a | 27.71M | 75.82M | n/a | n/a | 31.07M |
Operating Expenses | 39.6M | 104.36M | 224.81M | 137.64M | 80.98M | 41.32M |
Interest Expense | 298K | 289K | 5.12M | 298K | 927K | 2.52M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 61.85M | 134.76M | 251.36M | 159.5M | 95.08M | 47.05M |
Income Tax Expense | 67K | 33K | 62K | 1.88M | -5.72M | 29K |
Shares Outstanding (Basic) | 5.45M | 1.27M | 569.17K | 482.02K | 461.3K | 173.75K |
Shares Outstanding (Diluted) | 5.45M | 1.27M | 569.17K | 482.02K | 461.3K | 173.75K |
EPS (Basic) | -4.85 | -88.13 | -408.48 | -275.09 | -157.02 | -236.58 |
EPS (Diluted) | -4.85 | -88.13 | -408.48 | -275.09 | -157.02 | -236.58 |
EBITDA | -16.3M | -97.47M | -213.6M | -120.32M | -73.86M | -35.57M |
EBIT | -26.03M | -111.7M | -227.31M | -130.41M | -77.23M | -37.05M |
Depreciation & Amortization | 9.73M | 14.23M | 13.71M | 10.1M | 3.37M | 1.48M |
Add to Watchlist
Select watchlists to add or remove BNGO